President and Chief Executive Officer
My goal is to "do the right thing" for all Analyte stakeholders. Every day, I strive to understand the needs of our customers to take care of their health; identify the value proposition that is going to build our business to meet those needs; and build the team that can develop the best products and services to deliver that value. I also work hard to instill a sense of shared purpose in our team, and to support and facilitate the process of collective fact-finding, vigorous debate and decisionmaking.
Throughout my career, I have been involved with emerging businesses started by visionary founders and backed by stellar investors. My 20 years' experience include being part of the early days of enterprise software companies like Remedy, Ariba and Get2Chip; as well as the SaaS software offerings of CollabNet and consumer Internet offerings like TicketsNow. Though these businesses varied in size and scale - some going public and others being bought by public companies - they all shared a key success factor: passionate people who truly enjoyed solving customer problems in unique and innovative ways. In some cases, these innovations involved disruptions through new technologies; in other cases, the means and methods involved disruptions through business model innovations.
I am delighted to be a part of the great group of people at Analyte who constantly explore new and meaningful ways to bring quality healthcare services to our customers through business model and technology-enabled innovations.
Matthew McCall is a Partner at New World Ventures and co-founder of Draper Fisher Jurvetson Portage Venture Partners. Matthew has been responsible for managing investments in Analyte Media, Apptera, BrightTag, Cognitive Concepts (acquired by Houghton Mifflin), EverDream (acquired by Dell), Feedburner (acquired by Google), Imago Scientific (acquired by Ametek), Lefthand Networks (acquired by HP), Performics (acquired by Doubleclick/Google), Playdom (acquired by Disney), Siimpel (acquired by Tessera) and TicketsNow (acquired by Ticketmaster).
Matthew has been honored by Crain's Chicago Business on its annual "40 under 40" list of leading Chicagoans under age 40. He has also been named to the AlwaysOn Top 100 VC's in the United States, and as one of the most prominent members of Chicago's technology community. Additionally, Matthew has keynoted or been a panelist at more than 50 area conferences and events nationwide, and he’s a founder and trustee of the McCall Family Foundation, focused on improving early childhood development in Chicago's disadvantaged communities and encouraging entrepreneurship in our youth. He has served on numerous regional high technology advisory boards, and serves as an executive board member of the Illinois Venture Capital Association and on the Kellogg Alumni Council.
Before 1995, he worked in the Boston Consulting Group's Chicago office, where he managed consulting and client teams on projects in the telecommunications, healthcare and financial services industries. During and after college, Matthew worked for Bankers Trust in Merchant Banking as well as at Merrill Lynch and U.S. Trust. He holds a BA in economics and history from Williams College, an MBA with honors from Northwestern University's J.L. Kellogg Graduate School of Management and a master's degree in Manufacturing Management from Northwestern University's McCormick School of Engineering. Matthew authors a popular venture blog.
Lon Chow is a general partner with Apex Venture Partners, a Chicago-based venture capital firm. Prior to joining Apex in 1997, Lon was a partner with Mercer Management Consulting (formerly Strategic Planning Associates), where he developed and implemented growth strategies for clients in computing, media and telecommunications industries. He also held various operating management positions with Pacific Telesis.
Lon serves or previously served as director of Advanced Equities, Austin Logistics, CrowdBurst (acquired by Informative), Current Analysis, ICON Solutions (acquired by AnswerThink), KnowledgeStorm, Inc. (acquired by TechTarget), PlaceWare (acquired by Microsoft), Shoebuy.com (acquired by IAC/InterActiveCorp), Thinque Systems (acquired by MEI) and Xperex Corporation. He served as board observer of – and worked extensively with – the management teams of TRADEX Technologies (acquired by Ariba) and WorldPrints (acquired by At Home).
Lon received an MBA from the Wharton School and a BA from the University of California, Davis.
Vance Vanier, M.D. is the CEO and President of Navigenics. Dr. Vanier has spent the last decade of his career bringing breakthrough technologies to new markets as a leader in the field of personalized medicine and digital health. After working as an emergency physician on the front lines of medicine and observing first hand the overwhelming need for new health technologies, Dr. Vanier became a partner in the life sciences practice at Mohr Davidow Ventures (MDV), one Silicon Valley's most respected venture capital firms with $2 Billion under management. At MDV, Dr. Vanier invested in and guided groundbreaking companies in the molecular and electrical diagnostic space including iRhythm, CardioDx, and Crescendo Biosciences. Recognizing the early promise of genomics, he joined Navigenics in early 2008 as the company’s first Chief Medical Officer.
Dr. Vanier created a vision for Navigenics built around a powerful idea - that the most effective and responsible way to introduce preventive genomic testing to the public was with the support and partnership of health plans, corporate medical directors, medical centers, and physician offices, in addition to Navigenics’ own team of genetic counselors. Within two years, he built a series of clinical collaborations and distribution relationships that have made Navigenics the #1 physician endorsed company in the preventive genomics space. These achievements include orchestrating the Scripps Genomic Health Initiative, one of the largest behavioral genomics initiative in the U.S., partnering with premier national physician groups such as MDVIP with its 100,000 patients, and building a network of large self-insured marquee employers who are incorporating Navigenics into their wellness and benefit programs.
He became CEO in late 2009, subsequently raised 3 rounds of venture capital financing during an extremely challenging economic climate, and successully brought aboard Procter & Gamble and Highmark Health Plan as strategic investors and distributors. Recognizing the emerging market potential for the molecular diagnostic industry, he became the first in his industry to lead international expansion efforts in China and India resulting in early distribution agreements with these nations' premier health check and hospital channels. Navigenics was sold to Life Technologies (LIFE) in 2012 and featured as the centerpiece of their new clinical diagnostics and physician Health IT market initiative.
Dr. Vanier continues to serve on the clinical faculty of Stanford Medical Center. Dr. Vanier received his medical degree from the Johns Hopkins School of Medicine and completed his residency training at the University of California, San Francisco, and Highland Hospital in Oakland, CA. He received an MBA from Stanford University, as well as dual bachelor's degrees with honors. Dr. Vanier was named a Henry Crown Fellow to the Aspen Institute in 2011 and voted to San Francisco's Top 40 Under 40 in 2012.
Co-founder and Vice President of Business Development
My job is to discover and analyze new product and market opportunities for our Online Clinics.
I have been part of the business of technology startups nearly my entire career, starting as a software developer in 1990 after spending two years at Anderson Consulting (now Accenture). I co-founded a software company in 1992 and an online gaming company in 1996, in both cases running the business by day and writing code by night. In 1998, I gave up being a software entrepreneur and became a full-time venture capital investor at Flatiron Partners. From 2001 to 2008, I was an independent angel investor with Feedburner, TicketsNow and several other web-based companies.
On a personal level, I was raised in the farm country of north central Indiana. I fondly remember my first job detasseling corn (maybe not so fondly, for those of you who have ever done it!). I received an engineering degree from Purdue University, an MBA from Northwestern and I'm an alumni of the Kauffman Fellows Program. For anyone interested in learning more, visit my blog.
